Who are sodium selenite pentahydrate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): N-Acetyl Cysteine (NAC), Vitamin C (Ascorbic Acid), Acetylcysteine (NAC), Alpha-Lipoic Acid(α-LA), Coenzyme Q10 (drug), Grape Seed Extract.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-selenite-pentahydrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

sodium selenite pentahydrate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

sodium selenite pentahydrate (sodium selenite pentahydrate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant. Area: Oxidative stress and inflammation-related diseases.

phase 3 Antioxidant Oxidative stress and inflammation-related diseases Small molecule Live · refreshed every 30 min

Target snapshot

sodium selenite pentahydrate (sodium selenite pentahydrate) — Seoul National University Hospital. Sodium selenite pentahydrate is a selenium compound that acts as an antioxidant and has been investigated for its potential to reduce oxidative stress and inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
sodium selenite pentahydrate TARGET	sodium selenite pentahydrate	Seoul National University Hospital	phase 3	Antioxidant
N-Acetyl Cysteine (NAC)	N-Acetyl Cysteine (NAC)	The Aurum Institute NPC	marketed	Antioxidant / Mucolytic agent	Glutathione synthesis pathway; reactive oxygen species (non-specific)
Vitamin C (Ascorbic Acid)	Vitamin C (Ascorbic Acid)	M.D. Anderson Cancer Center	marketed	Antioxidant / Micronutrient
Acetylcysteine (NAC)	Acetylcysteine (NAC)	Clinica Universidad de Navarra, Universidad de Navarra	marketed	Mucolytic agent; antioxidant	Glutathione synthesis; disulfide bonds in mucoproteins
Alpha-Lipoic Acid(α-LA)	Alpha-Lipoic Acid(α-LA)	Shanghai Zhongshan Hospital	marketed	Antioxidant/Mitochondrial cofactor
Coenzyme Q10 (drug)	Coenzyme Q10 (drug)	University of Shizuoka	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I-III, Complex IV)
Grape Seed Extract	Grape Seed Extract	Al-Azhar University	marketed	Botanical/nutraceutical antioxidant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant class)

All India Institute of Medical Sciences, Bhubaneswar · 1 drug in this class
Hospices Civils de Lyon · 1 drug in this class
Hospital General Universitario Elche · 1 drug in this class
Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). sodium selenite pentahydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-selenite-pentahydrate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab